Sudeep Pharma Limited (NSE:SUDEEPPHRM)
560.90
+19.30 (3.56%)
At close: Jan 23, 2026
Sudeep Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2004 | 2003 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '04 Mar 31, 2004 | 2003 |
Net Income | 1,495 | 1,387 | 1,332 | 623.21 | 497.99 | - | Upgrade |
Depreciation & Amortization | 124.66 | 104.99 | 89.21 | 78.29 | 47.06 | - | Upgrade |
Other Amortization | 0.92 | 0.92 | 0.92 | 0.89 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -1.16 | 0.41 | -0.02 | 0.84 | 0.03 | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.09 | -0.09 | -0.94 | -0.33 | -0.51 | - | Upgrade |
Provision & Write-off of Bad Debts | 0.59 | 5.96 | -3.04 | 61.55 | 3.23 | - | Upgrade |
Other Operating Activities | 70.62 | 78 | 17.12 | 50.23 | 19.95 | - | Upgrade |
Change in Accounts Receivable | -279.79 | -406.57 | -498.91 | 79.02 | -517.42 | - | Upgrade |
Change in Inventory | -804.46 | -620.88 | 44.15 | -344.62 | -190.67 | - | Upgrade |
Change in Accounts Payable | 220.37 | 105.85 | 122.24 | 79.88 | 117.35 | - | Upgrade |
Change in Other Net Operating Assets | -414.01 | -168.61 | -445.99 | -145.01 | -3.4 | - | Upgrade |
Operating Cash Flow | 412.18 | 487.27 | 656.85 | 483.95 | -26.39 | - | Upgrade |
Operating Cash Flow Growth | -37.25% | -25.82% | 35.73% | - | - | - | Upgrade |
Capital Expenditures | -645.09 | -642.33 | -499.86 | -471.53 | -577.54 | - | Upgrade |
Sale of Property, Plant & Equipment | 2.11 | 3.4 | 0.59 | 0.4 | 0.36 | - | Upgrade |
Sale (Purchase) of Real Estate | - | - | -24.76 | - | - | - | Upgrade |
Investment in Securities | -257.51 | -150 | 30 | -30 | 192.31 | - | Upgrade |
Other Investing Activities | 8.85 | 1.37 | 1.22 | 0.97 | 0.72 | - | Upgrade |
Investing Cash Flow | -2,177 | -787.56 | -492.8 | -500.16 | -384.15 | - | Upgrade |
Short-Term Debt Issued | - | 296.61 | 9.22 | 33.37 | 384.98 | - | Upgrade |
Long-Term Debt Issued | - | 380 | 10 | - | 205.38 | - | Upgrade |
Total Debt Issued | 617.2 | 676.61 | 19.22 | 33.37 | 590.36 | - | Upgrade |
Long-Term Debt Repaid | - | -95.42 | -108.97 | -84.65 | -66.44 | - | Upgrade |
Net Debt Issued (Repaid) | 528.47 | 581.19 | -89.75 | -51.28 | 523.92 | - | Upgrade |
Other Financing Activities | -70.44 | -54.23 | -37.6 | -46.49 | -18.2 | - | Upgrade |
Financing Cash Flow | 2,058 | 526.96 | -127.35 | -97.77 | 505.72 | - | Upgrade |
Foreign Exchange Rate Adjustments | 3.21 | 1.64 | 0.05 | 2.26 | - | - | Upgrade |
Net Cash Flow | 333.43 | 228.31 | 36.75 | -111.72 | 95.18 | - | Upgrade |
Free Cash Flow | -232.92 | -155.06 | 157 | 12.42 | -603.93 | - | Upgrade |
Free Cash Flow Growth | - | - | 1164.05% | - | - | - | Upgrade |
Free Cash Flow Margin | -4.15% | -3.09% | 3.42% | 0.29% | -17.52% | - | Upgrade |
Free Cash Flow Per Share | -2.15 | -1.43 | 1.45 | 0.11 | -5.57 | - | Upgrade |
Cash Interest Paid | 70.44 | 54.23 | 37.6 | 46.49 | 18.2 | - | Upgrade |
Cash Income Tax Paid | 364.28 | 405.5 | 447.47 | 224.2 | 175.44 | - | Upgrade |
Levered Free Cash Flow | - | -493.92 | -161.13 | -168.82 | - | - | Upgrade |
Unlevered Free Cash Flow | - | -459.8 | -137.26 | -140.18 | - | - | Upgrade |
Change in Working Capital | -1,278 | -1,090 | -778.51 | -330.73 | -594.14 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.